Furthermore, breast cancers in general upregulate the PI3K signaling pathway through the expression of constitutive active or amplification of PIK3CA and deletion of PTEN or INPP4B or Akt mutations (Nik-Zainal et al., 2016). This evidence concerns the gene PIK3CA and breast cancer.